FDA and Drug Litigation |
Article: Requip Linked To Compulsive Gambling, Sexual & Other Intense UrgesGlaxoSmithKline’s drug, Requip, which is prescribed for the treatment of Parkinson’s Disease and Restless Leg Syndrome, has been linked to a host of bizarre side effects including compulsive gambling, sexual urges and other intense urges.
Mayo Clinic study Requip – a dopamine agonist – stimulates the nerves in the brain which are normally stimulated by dopamine – a chemical in the brain which helps control motor functions and movement. Researchers at the renowned Mayo Clinic have suggested that a link exists between dopamine agonist drugs, sexual urges and other intense urges and Requip. Patients who stopped taking the drug or reduced the dosage found that these symptoms were alleviated. Since the Clinic’s study, GlaxoSmithKline added language to the drug’s label which states:
Boehringer Ingelheim’s Mirapex also studied Mirapex, a similar drug to Requip but manufactured by Boehringer Ingelheim, has also been linked to the same intense urges and was identified in the Mayo Clinic’s study. The company has included a similar warning on the label of Mirapex. Lawsuits filed According to news reports, lawsuits have been filed against GSK alleging that the company did not warn consumers about the possibility of these urges and many users – who had never gambled in their lives – became compulsive gamblers as a result of taking the medication. The lawsuits allege that the company should pay back those who have lost money due to compulsive gambling. As strange as that may sound to many of us, compulsive gambling is a serious disorder. In fact, according to the Mayo Clinic:
If you’ve been injured by Requip or any type of dangerous drug, contact an experienced drug litigation attorney to discuss your situation and evaluate your options. Consultations are free, without obligation and are strictly confidential. Articles & Information:Proposed FDA Warning Requirements Not Consumer Friendly Study Finds Drug Makers Not Reporting All Trial Results Consumer Group Claims Botox Injections Linked To 16 Deaths FDA Gets More Money – But Will It Really Help Consumers? View all articles |